Overview

Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetic interaction between etravirine and artemether/lumefantrine and darunavir/ritonavir and artemether/lumefantrine in healthy Human Immunodeficiency Virus- (HIV-)negative patients. 'Pharmacokinetic interaction' means that one medication can influence the absorption and elimination from the body of the other medication.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium
Treatments:
Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinins
Darunavir
Etravirine
Lumefantrine
Ritonavir